RECOVERY Trial publishes tocilizumab results
12 February, 2021
The Taskforce notes the publication of results of the tocilizumab arm of the RECOVERY trial in medRxiv Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial on February 11. The Taskforce Disease Modifying Treatment and Chemoprophylaxis Panel will review the data from this important trial and incorporate the results into the...